Track record
Our Case StudiesSupporting our clients across the globe with successful deal-making
Featured Case Studies
M&A
Licensing
Fundraising
Our Projects
PharmaVentures advises Wellmarker Bio on their Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA® (pembrolizumab)
PharmaVentures advises Lausanne Hospital (CHUV) and EPFL on their collaboration and founding of Aerium Therapeutics to develop their highly potent SARS-CoV-2 antibodies
PharmaVentures acts as independent commercial expert with respect to Spectral MD’s IPO listing this month on London’s AIM
PharmaVentures advises Novartis on the sale of its manufacturing facility in Barberà del Vallès to Siegfried Holding AG
PharmaVentures advises Vital Foods on the sale of its Zyactinase-based digestive health product asset portfolio to Mundipharma
PharmaVentures Capital Limited advises Biosceptre International Limited, a clinical stage oncology company, on its Series A private placement by Tuspark S&T
PharmaVentures advises IDT Australia on the divestment of CMAX clinical trial business to the Japanese company I’rom Group Co. Ltd.
PharmaVentures advises the Baylor Scott & White Research Institute on collaboration with Abzena plc and creation of Denceptor Therapeutics
PharmaVentures advises 3Legs Resources on its acquisition of the Immuno-Oncology company SalvaRx who announced its admission for trading on AIM today
PharmaVentures’ Latest Deal: Douglas Pharmaceuticals acquires Vital Foods’ Phloe product line in New Zealand
PharmaVentures Advises ESTEVE in Its pharma licensing Deal for E-58425, a New Therapeutic Product for Pain
PharmaVentures Advises MedGenesis in Agreement with Pfizer for Its Potential Therapy for Parkinson’s Disease
PharmaVentures Acts as Exclusive Advisor to Sanofi in the Divestment of Zentiva’s Hlovovec Production Facility to Wood Pharma Holding
Our Clients











What Our Clients Say
“I was most impressed with the professionalism in evidence at PharmaVentures ….our profound thanks and appreciation, this was a job well done!”
“We have…. retained the services of PharmaVentures ……their contribution has been invaluable….”
“[We are] very, very pleased with the result; your report was instrumental……..it was a pleasure working with you on this matter…….your work helped us obtain a good result.”
“We were able to start licensing negotiations on several new products in a very short time period with the assistance of the highly professional and well organized experts from PV.”
“I’ve just spoken with [future client name withheld] commenting to him on the very positive experience we had with you (PharmaVentures) some time ago and frankly telling him that, should we have to repeat a similar experience in the future, we would contact you again without doubt to help us with your advice.”
“We have found PharmaVentures extremely valuable and uniquely frank in the way you have advised us…..we feel that you are very much part of our team. We would like to thank you for your efforts.”
“I was Head of Business Development at [name withheld], Inc. New Jersey, USA. PharmaVentures conducted a highly professional market evaluation study and the company decided to enter the acute care pharmaceutical market in Europe. I have no hesitation in giving PharmaVentures a first class reference.”
“We hired PharmaVentures when our management team decided that as a matter of urgency, we needed to identify and secure products to replace a product line in the short term. Within a two-months-period, the excellent team at PV identified more than 60 product opportunities for us and initiated CDA’s and first contacts with the most interesting of them.”
